AG
DYN icon

Algert Global’s Dyne Therapeutics DYN Stock Holding History

Algert Global’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.24M Buy
454,463
+183,160
+68% +$3.16M 0.12% 270
2025
Q4 		$5.31M Sell
271,303
-243,829
-47% -$4.62M 0.08% 412
2025
Q3 		$6.52M Sell
515,132
-43,764
-8% -$499K 0.11% 330
2025
Q2 		$5.32M Buy
558,896
+82,889
+17% +$913K 0.11% 304
2025
Q1 		$4.98M Buy
476,007
+395,084
+488% +$5.65M 0.12% 277
2024
Q4 		$1.91M Sell
80,923
-14,037
-15% -$415K 0.04% 622
2024
Q3 		$3.41M Sell
94,960
-2,410
-2% -$95.9K 0.09% 379
2024
Q2 		$3.44M Buy
97,370
+69,947
+255% +$2.03M 0.11% 291
2024
Q1 		$779K Sell
27,423
-133,581
-83% -$3.02M 0.03% 682
2023
Q4 		$2.14M Buy
161,004
+2,291
+1% +$22.4K 0.09% 395
2023
Q3 		$1.42M Sell
158,713
-80,359
-34% -$866K 0.07% 482
2023
Q2 		$2.69M Buy
239,072
+47,200
+25% +$557K 0.12% 279
2023
Q1 		$2.21M Buy
191,872
+38,227
+25% +$496K 0.1% 308
2022
Q4 		$1.78M Sell
153,645
-1,450
-0.9% -$16.8K 0.1% 332
2022
Q3 		$1.97M Buy
155,095
+136,540
+736% +$1.57M 0.12% 274
2022
Q2 		$127K Buy
+18,555
New +$128K 0.01% 1084

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Algert Global's DYN Position: Q1 2026 in Review

Algert Global increased its Dyne Therapeutics (DYN) stake by 68% in Q1 2026, buying an estimated $3.16M and bringing the position to 454,463 shares worth $8.24M. The position accounts for 0.12% of the portfolio, ranked #270.

Algert Global first reported a position in DYN in Q2 2022 and has held it in 16 quarters since. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Algert Global held 454,463 shares of Dyne Therapeutics worth $8.24M as of Q1 2026.
  • Algert Global bought 183,160 Dyne Therapeutics shares in Q1 2026, an estimated $3.16M.
  • Dyne Therapeutics made up 0.12% of Algert Global's portfolio in Q1 2026, its #270 holding.
  • Algert Global first reported a position in Dyne Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.